Medical device coating methods and devices

Details Medical device coating methods and devices Medical device coating methods and devices

1999-05-03

2000-12-05

Beck, Shrive

Coating processes

Medical or dental purpose product; parts; subcombinations;...

Device for creating or holding open an unnatural opening in...

427 23, 427348, 427378, 427232, 427235, A61L 3300, B05D 304, B05D 302, B05D 722

Patent

active

061563730

ABSTRACT:
Devices and methods for applying a polymeric coating to a medical device. The steps of the coating process including applying a liquid polymeric material to the surface of the medical device, then directing a stream of gas to impinge on the surface of the medical device. Excess liquid polymeric material is removed from the surface of the medical device. The devices used in the coating process and the coated medical device are also part of this invention.

REFERENCES:
patent: 3946125 (1976-03-01), Scheiber
patent: 4391797 (1983-07-01), Folkman et al.
patent: 4459317 (1984-07-01), Lambert
patent: 4487808 (1984-12-01), Lambert
patent: 4768507 (1988-09-01), Fischell et al.
patent: 4770664 (1988-09-01), Gogolewski
patent: 4842575 (1989-06-01), Hoffman, Jr. et al.
patent: 4923464 (1990-05-01), DiPisa, Jr.
patent: 4969890 (1990-11-01), Sugita et al.
patent: 4994071 (1991-02-01), MacGregor
patent: 5019096 (1991-05-01), Fox, Jr. et al.
patent: 5092885 (1992-03-01), Yamada et al.
patent: 5102402 (1992-04-01), Dror et al.
patent: 5102417 (1992-04-01), Palmaz
patent: 5192308 (1993-03-01), Ostapchenko
patent: 5222971 (1993-06-01), Willard et al.
patent: 5258202 (1993-11-01), Pellegrino et al.
patent: 5282823 (1994-02-01), Schwartz et al.
patent: 5304121 (1994-04-01), Sahatjian
patent: 5324261 (1994-06-01), Amundson et al.
patent: 5370614 (1994-12-01), Amundson et al.
patent: 5380299 (1995-01-01), Feranot et al.
patent: 5383928 (1995-01-01), Scott et al.
patent: 5419760 (1995-05-01), Narciso, Jr.
patent: 5423885 (1995-06-01), Williams
patent: 5443458 (1995-08-01), Eury
patent: 5443496 (1995-08-01), Schwartz et al.
patent: 5447724 (1995-09-01), Helmus et al.
patent: 5449372 (1995-09-01), Schmaltz et al.
patent: 5449382 (1995-09-01), Dayton
patent: 5464650 (1995-11-01), Berg et al.
patent: 5512055 (1996-04-01), Domb et al.
patent: 5514154 (1996-05-01), Lau et al.
patent: 5527337 (1996-06-01), Stack et al.
patent: 5545208 (1996-08-01), Wolff et al.
patent: 5562922 (1996-10-01), Lambert
patent: 5569463 (1996-10-01), Helmus et al.
patent: 5578075 (1996-11-01), Dayton
patent: 5591227 (1997-01-01), Dinh et al.
patent: 5605696 (1997-02-01), Eury et al.
patent: 5609629 (1997-03-01), Fearnot et al.
patent: 5611151 (1997-03-01), Jacob
patent: 5616608 (1997-04-01), Kinsella et al.
patent: 5624411 (1997-04-01), Tuch
patent: 5626862 (1997-05-01), Brem et al.
patent: 5635201 (1997-06-01), Fabo
patent: 5637113 (1997-06-01), Tartaglia et al.
patent: 5651986 (1997-07-01), Brem et al.
patent: 5674192 (1997-10-01), Sahatjian et al.
patent: 5674241 (1997-10-01), Bley et al.
patent: 5674242 (1997-10-01), Phan et al.
patent: 5679400 (1997-10-01), Tuch
patent: 5697967 (1997-12-01), Dinh et al.
patent: 5700286 (1997-12-01), Tartaglia et al.
patent: 5702754 (1997-12-01), Zhong
patent: 5709874 (1998-01-01), Hanson et al.
patent: 5712326 (1998-01-01), Jones et al.
patent: 5716981 (1998-02-01), Hunter et al.
patent: 5733925 (1998-03-01), Kunz et al.
patent: 5739237 (1998-04-01), Russell et al.
patent: 5755769 (1998-05-01), Richard et al.
patent: 5776184 (1998-07-01), Tuch
patent: 5779732 (1998-07-01), Amundson
patent: 5824391 (1998-10-01), Asanuma
patent: 5837008 (1998-11-01), Berg et al.
patent: 5958512 (1999-09-01), Krish et al.
Bartoli et al., "In Vitro and In Viro Antiumoral Activity of Free, and Encapsulated Taxol", J. Microencapsulation, vol. 7, No. 2 (1990) pp. 191-97.
Bruck, Stephen, "Interactions of Synthetic and Natural Surfaces with Blood in the Physiological Environment," J. Biomed. Materi. Res. Symposium, No. 8 (1977) pp. 1-21.
Cox, David A., M.D. et al., "Effects of local Delivery of Heparin and Methotrexate on Neointimal Proliferation in Stented Porcine Coronary Arteries", Coronary Artery Disease, vol. 3, No. 3, Mar. 1992, pp. 237-248.
Cox, D. A. et al., "Local Delivery of Heparin and Methotrexate Fails to Inhibit In Vivo Smooth Muscle Cell Proliferation", Supplement to Circulation Abstracts From the 64.sup.th Scientific Sessions, vol. No. 4, Abstract No. 0284, 1991, p. II-71.
Dev, V. et al. "Kinetics of Drug Delivery to the Arterial Wall via Polyurethane Coated Removable Nitinol Stent-Comparative Study of Drugs 2 ", Circulation Abstacts From the 66.sup.th Scientific Sessions, vol. 88, No. 4, Part 2, Abstract No. 1657 (1993) P. I-3.
Esquivel, Carlos O., M.D. et al.,"Reduced Thrombogenic Characteristics of Expanded Polyetrafluoroethylene and Polyurethane Arterial Grafts After Heparin Bonding," Surgery, vol. 95, No. 1, Jan. 1984, pp. 102-107.
Guyton, John R. et al., "Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin," Circulation Research, vol. 46, No. 5, May 1980, pp. 625-634.
Jampel, Henry D., M.D. et al., "In Vitro Release of Hydrophobic Drugs From Polyanhydride Disks", Ophthalmic Surgery, dated prior to Jan. 8, 1991.
Kawahito, Kohi et al. "Heparin Coated Percutaneous Cardiopulmonary Support for the Treatment of Circulatory Collapse After Cardiac Surgery,"ASAIO Journal, vol. 40, No. 4, Oct.-Dec. 1994, pp. 972-976.
Kishida, Akio et al., "Immobilization of Human Thrombomodulin onto Biomaterials," ASAIO Journal(1994) pp. M840-M845.
Lambert, T. et al., "A New Method For Arterial Drug Delivery Via Removable Stant", JACC, vol. 21, No. 2, Abstract No. 834-2 (1993) p. 483A.
Lambert, T. et al., "Localized Arterial Drug Delivery From a Polymer Coated Removable Metallic Stent: Kinetics and Bioactivity of Forskolin", Circulation Abstract From the 66.sup.th scientific Sessions, vol. 88, No. 4, Part 2, Abstract No. 1659 (1993) p. I-3.
Linhardt, Robert J. et al., "Differential Anticoagulant Activity of Heparin Fragments Prepated Using Microbial Heparinase," The Journal of Biological Chemist, vol. 257, No. 13, Issue of Jul. 10, pp. 7310-7313.
Miyama, Hajime et al., "A New Antithrombogenic Heparinized Polymer," J.Biomed Mater. Res., vol. 11 (1977) pp. 251-265.
Moses, Marsha A. et al., Inhibitors of Angiogenesis, Review, The Childern's Hospital Medical Center, Boston, MA dated prior to Jan. 8, 1999.
Nichols, Allen B., M.D. et al., "Effect of Heparin Bonding on Catheter-Induced Fibrin Formation and Platelet Activation," Circulation, vol. 70, No. 5, Nov. 1984, pp. 843-850.
"A Powerful Case For LOPID", Parke-Davis, dated prior to Jan. 8, 1999.
Pitt, C.G. et al. "The Design of Controlled Drug Delivery Systems Based on Biodegredable Polymers", Progress in Contraceptive Delivery Systems, M T P Press, Lancaster, vol. 1 (1980) pp. 17-18.
Sheppeck, Richard A. et al., "Examination of the Roles of Glycoprotein Ib and Glyoprotein IIb/IIIa in Platelet Deposition on an Artificial Surface Using Clinical Antiplatelet Agents and Monoclonal Antibody Blockade,"blood, vol. 78, No. 3, Aug. 1, 1991, pp. 673-680.
Tang, Chris et al. "Regression of Collagen-Induced Arthritis with Taxol, A Microtubule Stablizer", Arthritis Rheum., vol. 36, No. 9 (Suppl.) (1993) p. 42.
Whiteborn, Richard, Ph.D., Presentation at the 2.sup.nd International Coronary Stenting Summit (Mar. 1-2 1991).

Affiliated with

Also associated with

Rating

Medical device coating methods and devices does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medical device coating methods and devices, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical device coating methods and devices will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-959234